US equities
|
MU
$919.41
▲+0.58%
NVDA
$217.26
▼-1.83%
SNDK
$1,366.00
▼-2.66%
SPCX
$148.43
▼-2.45%
AMD
$549.46
▼-3.74%
INTC
$94.33
▼-3.86%
TSM
$419.46
▼-2.45%
TSLA
$363.14
▼-1.09%
MU
$919.41
▲+0.58%
NVDA
$217.26
▼-1.83%
SNDK
$1,366.00
▼-2.66%
SPCX
$148.43
▼-2.45%
AMD
$549.46
▼-3.74%
INTC
$94.33
▼-3.86%
TSM
$419.46
▼-2.45%
TSLA
$363.14
▼-1.09%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Latest News about AEMPS
Recent news which mentions AEMPS
Aelis Farma's Drug Candidate For the Treatment Of Cognitive Disorders Authorized For The First Trial In People With Down Syndrome
November 17, 2022
Tags
Benzinga
News
Cannabis
From
Benzinga